Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Ames

Showing results (121-130 of 335) with videos related to

Pageof 34
Sort By:
The Lancet. Neurology|August 2, 2008
Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trialLars Lannfelt, Kaj Blennow, Henrik Zetterberg, et al.
Life (Basel, Switzerland)|August 13, 2020
Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer's Disease in the AIBL Study of AgeingMohammad Sabbir Siddiqui, Maxime Francois, Stephanie Rainey-Smith, et al.
International Psychogeriatrics|January 17, 2012
Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementiaClaudia Cooper, Naaheed Mukadam, Cornelius Katona, et al.
Current Alzheimer Research|March 15, 2017
Modulation of Retinal Arteriolar Central Reflection by APOE GenotypeShaun Frost, Alauddin Bhuiyan, David Offerman, et al.
International Psychogeriatrics|July 14, 2011
Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageingAlessandro Sona, Ping Zhang, David Ames, et al.
BMC Psychology|January 8, 2015
Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's diseasePaul Maruff, Yen Ying Lim, David Darby, et al.
Nature Communications|August 5, 2022
Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer's diseaseKonstantinos Poulakis, Joana B Pereira, J-Sebastian Muehlboeck, et al.
Annals of Epidemiology|November 12, 2013
Influence of population versus convenience sampling on sample characteristics in studies of cognitive agingHenry Brodaty, Annu Mothakunnel, Melissa de Vel-Palumbo, et al.
Neurobiology of Aging|September 27, 2014
Comparison of MR-less PiB SUVR quantification methodsPierrick Bourgeat, Victor L Villemagne, Vincent Dore, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease RiskWayne R Leifert, Tori Nguyen, Alan Rembach, et al.
Pageof 34

Showing results (121-130 of 335) with videos related to

Sort By:
Pageof 34
The Lancet. Neurology|August 2, 2008
Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trialLars Lannfelt, Kaj Blennow, Henrik Zetterberg, et al.
Life (Basel, Switzerland)|August 13, 2020
Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer's Disease in the AIBL Study of AgeingMohammad Sabbir Siddiqui, Maxime Francois, Stephanie Rainey-Smith, et al.
International Psychogeriatrics|January 17, 2012
Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementiaClaudia Cooper, Naaheed Mukadam, Cornelius Katona, et al.
Current Alzheimer Research|March 15, 2017
Modulation of Retinal Arteriolar Central Reflection by APOE GenotypeShaun Frost, Alauddin Bhuiyan, David Offerman, et al.
International Psychogeriatrics|July 14, 2011
Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageingAlessandro Sona, Ping Zhang, David Ames, et al.
BMC Psychology|January 8, 2015
Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's diseasePaul Maruff, Yen Ying Lim, David Darby, et al.
Nature Communications|August 5, 2022
Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer's diseaseKonstantinos Poulakis, Joana B Pereira, J-Sebastian Muehlboeck, et al.
Annals of Epidemiology|November 12, 2013
Influence of population versus convenience sampling on sample characteristics in studies of cognitive agingHenry Brodaty, Annu Mothakunnel, Melissa de Vel-Palumbo, et al.
Neurobiology of Aging|September 27, 2014
Comparison of MR-less PiB SUVR quantification methodsPierrick Bourgeat, Victor L Villemagne, Vincent Dore, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease RiskWayne R Leifert, Tori Nguyen, Alan Rembach, et al.
Pageof 34